EcoDrugPlus

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSLBEG00000012006
Gene Symbol: GRM2
3 Cross references
189 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSLBEG00000008769
Gene Symbol: GRM4
3 Cross references
196 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSLBEG00000024040
Gene Symbol: GRM4
3 Cross references
207 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSLBEG00000013604
Gene Symbol: LOC109981031
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSLBEG00000012269
Gene Symbol: LOC110002890
2 Cross references
237 Possible Orthologues:

Glutamate Receptor 3-Like

Ensembl ID : ENSLBEG00000002862
Gene Symbol: LOC109981486
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSLBEG00000024605
Gene Symbol: LOC109998953
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSLBEG00000019856
Gene Symbol: LOC109985652
3 Cross references
205 Possible Orthologues:

Glutamate Receptor Ionotropic, Kainate 1-Like

Ensembl ID : ENSLBEG00000014320
Gene Symbol: LOC109988376
2 Cross references
245 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSLBEG00000010576
Gene Symbol: LOC109994750
3 Cross references
227 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSLBEG00000016246
Gene Symbol: LOC110005900
2 Cross references
227 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSLBEG00000019323
Gene Symbol: LOC110003860
3 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).